A recent study by Wai et al. demonstrated that dilated cardiomyopathy and heart failure was induced when cardiac-specific ablation of Yme1l in mice activated OMA1 and hastened OPA1 proteolysis, leading to mitochondrial fragmentation and altered cardiac metabolism [184]. The gene discussed is OPA1; the disease is heart failure.